The Government have confirmed they will be offering the covid vaccine to children between 5 and 11-years old who are either clinically at risk or in the household of someone who is vulnerable.
It comes following advice from the Joint Committee on Vaccination and Immunisation (JCVI) that children in this age group can be given 10 microgram doses of the Pfizer/BioNTech covid-19 vaccine.
The Government is yet to give a date for when this provision will come, but said details will follow soon.
"Children aged 5 to 11 years in a clinical risk group or who are a household contact of someone who is immunosuppressed should be offered two 10 micrograms doses of the Pfizer/BioNTech COVID-19 vaccine, with an interval of 8 weeks between the first and second doses," a spokesperson said.
"The booster vaccine should be expanded to the following priority groups no sooner than 3 months after completion of their primary course:
"We acknowledge that the Medicines and Healthcare products Regulatory Agency (MHRA) have approved a new formulation of the Pfizer/BioNTech vaccine which has a smaller dose of 10 micrograms compared to the usual 30 micrograms, to be administered to children aged 5 to 11.
"This decision follows a robust review of safety data which showed a positive benefit risk profile for this vaccine to be used in this age group.
"We will await further advice from the JCVI regarding first and second doses for other 5 to 11 year olds following consideration of additional data.
"Jersey's Vaccination Programme follows the advice and guidance provided by the JCVI and the UK's Chief Medical Officers. As such, we will be incorporating the latest recommendations as outlined into our programme, with more details on how this will operate in Jersey to follow soon."
Comments on this story express the views of the commentator only, not Bailiwick Publishing. We are unable to guarantee the accuracy of any of those comments.
Once your comment has been submitted, it won’t appear immediately. There is no need to submit it more than once. Comments are published at the discretion of Bailiwick Publishing, and will include your username.
There are no comments for this article.